ATE179601T1 - Aufheben der resistenz von hiv-1 linien gegenüber zidovudine - Google Patents

Aufheben der resistenz von hiv-1 linien gegenüber zidovudine

Info

Publication number
ATE179601T1
ATE179601T1 AT94908308T AT94908308T ATE179601T1 AT E179601 T1 ATE179601 T1 AT E179601T1 AT 94908308 T AT94908308 T AT 94908308T AT 94908308 T AT94908308 T AT 94908308T AT E179601 T1 ATE179601 T1 AT E179601T1
Authority
AT
Austria
Prior art keywords
zidovudine
hiv
resistance
lines
viruses
Prior art date
Application number
AT94908308T
Other languages
English (en)
Inventor
Koenraad Jozef Lodewij Andries
Paulus Aloysius Maria Stoffels
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE179601T1 publication Critical patent/ATE179601T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Testing Or Measuring Of Semiconductors Or The Like (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Adornments (AREA)
AT94908308T 1993-02-22 1994-02-10 Aufheben der resistenz von hiv-1 linien gegenüber zidovudine ATE179601T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2128693A 1993-02-22 1993-02-22

Publications (1)

Publication Number Publication Date
ATE179601T1 true ATE179601T1 (de) 1999-05-15

Family

ID=21803366

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94908308T ATE179601T1 (de) 1993-02-22 1994-02-10 Aufheben der resistenz von hiv-1 linien gegenüber zidovudine

Country Status (11)

Country Link
EP (1) EP0684818B1 (de)
JP (1) JP2669937B2 (de)
CN (1) CN1118137A (de)
AT (1) ATE179601T1 (de)
AU (1) AU676021B2 (de)
CA (1) CA2155829A1 (de)
DE (1) DE69418312D1 (de)
OA (1) OA10226A (de)
SG (1) SG49651A1 (de)
WO (1) WO1994018963A1 (de)
ZA (1) ZA941178B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0872233A1 (de) * 1997-04-14 1998-10-21 Janssen Pharmaceutica N.V. Antiretrovirale Arzneimittel mit verbesserter Bioverfügbarkeit
PT1225874E (pt) 1999-09-24 2006-06-30 Janssen Pharmaceutica Nv Composicoes antivirais.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2038847T3 (es) * 1988-09-28 1993-08-01 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Proceso para la preparacion de una composicion farmacutica conteniendo zidovudine e inosiplex para el tratamiento del sida y sindromes afines.
IE75693B1 (en) * 1990-07-10 1997-09-10 Janssen Pharmaceutica Nv HIV-inhibiting benzeneacetamide derivatives
IL99843A0 (en) * 1990-11-01 1992-08-18 Merck & Co Inc Synergistic combination of hiv reverse transcriptase inhibitors

Also Published As

Publication number Publication date
EP0684818B1 (de) 1999-05-06
AU6139894A (en) 1994-09-14
DE69418312D1 (de) 1999-06-10
JPH08505642A (ja) 1996-06-18
AU676021B2 (en) 1997-02-27
ZA941178B (en) 1995-08-21
SG49651A1 (en) 1998-06-15
JP2669937B2 (ja) 1997-10-29
OA10226A (en) 1997-10-07
CN1118137A (zh) 1996-03-06
WO1994018963A1 (en) 1994-09-01
EP0684818A1 (de) 1995-12-06
CA2155829A1 (en) 1994-09-01

Similar Documents

Publication Publication Date Title
EA199700331A1 (ru) Тгф-содержащие сульфонамидные ингибиторы аспартил-протеазы
ES2103488T3 (es) N-(alcanoilamino-2-hidroxipropil)sulfonamidas utiles como inhibidores de proteasas retrovirales.
NO974744L (no) Oksygenert-heterocykelinneholdende sulfonamidhemmere av aspartylprotease
BR0011745A (pt) Inibidores de aspartil protease
ATE315667T1 (de) Amplifizierung und detektion von hiv-1 und/oder hiv-2
MY142901A (en) Novel sulfonamide inhibitors of aspartyl protease
BR9912169A (pt) Inibidores de sulfonamida de protease de aspartil
ES2043625T3 (es) Derivados de acido ariloxicarboxilico, su preparacion y empleo.
ES2155887T3 (es) Produccion de pentafluoroetano.
ES2052740T3 (es) Composiciones de cemento.
DE69414708D1 (de) Verbindungen und methoden zur inhibition von hiv und verwandten viren
ATE179601T1 (de) Aufheben der resistenz von hiv-1 linien gegenüber zidovudine
EA199800661A1 (ru) Ингибиторы аспартильных протеаз
ES2000908A6 (es) Procedimiento para la fabricacion de nuevos derivados de alquilmercaptofenil-1,3,4-oxadiazol
KR890701738A (ko) 인체면역결핍 비루스 특이성 단백질분해효소와 이들의 합성 및 원형재현 방법
DE69825269D1 (de) Nachweis von retroviralen untertypen auf der basis der spezifischen sequenzen der hülle
DK183779A (da) Fremgangsmaade til indibering af korrosion af staal med et lavt carboindhold og korrosionsinhibitor til brug ved udoevelse af fremgangsmaaden
GB1473602A (de)
ATE401573T1 (de) Tsg101 als inhibitor der hiv-produktion
DE69614127D1 (de) Eine familie von verbindungen mit entzündungshemmender und antiviraler aktivität und deren zusammensetzungen alleine oder in verbindung mit inhibitoren der reversen transcriptase zur inhibierung, vermeidung oder eliminierung viraler replikation und methoden zu ihrer verwendung
FR2621816B1 (fr) Application antivirale des ologonucleotides
TH14572EX (th) สารยับยั้งซัลโฟนามีดชนิดใหม่ของเอ็นไซม์ย่อยโปรตีนแอสพาร์ทิล
ES544873A0 (es) Un catalizador de polimerizacion y su procedimiento de fa- bricacion
SU815863A1 (ru) Цифровой частотный детектор
ATE240114T1 (de) Muramylpeptide zusammensetzungen für inhibierung von hiv replikation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties